# Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial)

Study · id `cardio:ct-nct07938281` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07938281](<https://clinicaltrials.gov/study/NCT07938281>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07938281

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1006 participants.

## Technical summary

Registry record NCT07938281. Randomized; double masking; primary purpose diagnostic. Start 2026-12-01 (anticipated); primary completion 2029-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 1006 participants (planned count; ClinicalTrials.gov record NCT07938281, source copy `cardio:ctgov-nct07938281-2026-11-17`, retrieved 2026-11-18)
- Planned start: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT07938281, source copy `cardio:ctgov-nct07938281-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2029-12-01 (anticipated) (ClinicalTrials.gov record NCT07938281, source copy `cardio:ctgov-nct07938281-2026-11-17`, retrieved 2026-11-18)
- Completion: 2030-06-01 (anticipated) (ClinicalTrials.gov record NCT07938281, source copy `cardio:ctgov-nct07938281-2026-11-17`, retrieved 2026-11-18)
- Countries: South Korea (ClinicalTrials.gov record NCT07938281, source copy `cardio:ctgov-nct07938281-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07938281-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial)
- Condition: AF - Atrial Fibrillation
- Intervention (Device): ECG Analysis Software AiTiALVDD
- Intervention (Device): ECG Analysis Software AiTiALVSD
- Lead sponsor: Korea University Anam Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Korea University Anam Hospital (`cardio:org-korea-university-anam-hospital`)

## Provenance

Content hash: bc0674e00b45e1bd0c9959f9ce9caa5d50d8f70a6edb6d76d45688b46513bcc9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
